Načítá se...
Antibody-mediated oral delivery of therapeutic DNA for type 2 diabetes mellitus
BACKGROUND: Diabetes mellitus (DM) is a chronic progressive metabolic disease that involves uncontrolled elevation of blood glucose levels. Among various therapeutic approaches, GLP-1 prevents type 2 diabetes mellitus (T2DM) patients from experiencing hyperglycemic episodes. However, the short half-...
Uloženo v:
| Vydáno v: | Biomater Res |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6062860/ https://ncbi.nlm.nih.gov/pubmed/30065848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40824-018-0129-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|